Find a research partner or other support function connected to the large scale research facilities, ESS & MAX IV. If you are not ready or not sure what you are looking for start here.
Center Consultation & CRO Laboratory & Lab instruments Large-scale Infrastructure Projects & Networks Research Institute Support organisation University
Clear All

Send us your feedback

Here you can send us feedback on the Maxess-website. Please describe the problem or what’s missing in a clear way, and on what page you found the issue. Thank you so much for your help!

    Industry access to world-leading research facilities

    MAXESS is a joint access point for industry to the large-scale research infrastructures MAX IV, ESS, DESY, and the associated networks.

    Discover cases, resources, and our network of experts

    Food and Agriculture

    More energy-efficient bread baking with synchrotron microtomography 

    Jun 2019 - Oct 2021

    Increased energy efficiency during bread baking can save time and energy, lower greenhouse gas emissions, and save money. Scientists from Finax and researchers from RISE and MAX IV used time-resolved synchrotron microtomography to explore ways to make bread baking more energy efficient. 

    Medtech - Biomedical engineering

    Identifying leaking syringes with neutrons

    Swedish Orphan Biovitrum AB
    Nov 2018 - Dec 2019

    The biopharmaceutical company Sobi together with neutron experts from RISE used neutron radiography for the detection of leakages in prefilled syringes. The results show the potential of this technique in detecting leaks, with significant advantages for design and quality assurance in syringe production.

    Pharma and Biotechnology

    Insights into better ways to package and deliver RNA into human cells

    BioNTech; University of Mainz; EMBL

    BioNTech, the biotech company that together with Pfizer developed one of the first COVID-19 vaccines, conducted scattering experiments at DESY’s synchrotron facility PETRA III in collaboration with the University of Mainz and the European Molecular Biology Laboratory (EMBL). Research questions and analyses were addressing the question how to better package mRNA in nanoparticles for vaccines or individualized drugs.